Volker Knappertz is Director at GW PHARMACEUTICALS PLC (GWPH). They have made 16 open-market trades across 2 companies since 2019, most recently 2024-02-27.
CIK 0001754122
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 16 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| AUPH | SELL | 2024-02-27 | 2024-02-29 | $6.10 | $30K | -9.2% | -5.8% | -9.9% |
| AUPH | SELL | 2024-02-20 | 2024-02-22 | $5.48 | $276K | -6.0% | -16.3% | -7.2% |
| GWPH | SELL | 2021-03-26 | 2021-03-30 | $18.10 | $111K | +0.2% | +0.9% | N/A |
| GWPH | SELL | 2021-01-19 | 2021-01-20 | $11.67 | $70K | +2.5% | +52.1% | +55.4% |
| GWPH | SELL | 2020-11-24 | 2020-11-25 | $10.50 | $126K | -1.0% | -9.1% | +67.4% |
| GWPH | SELL | 2020-11-11 | 2020-11-13 | $10.00 | $60K | +6.9% | +1.5% | +79.8% |
| GWPH | SELL | 2020-11-04 | 2020-11-05 | $9.17 | $55K | +11.2% | +21.2% | +94.2% |
| GWPH | SELL | 2020-08-04 | 2020-08-06 | $11.11 | $67K | -11.3% | -15.8% | -7.8% |
| GWPH | SELL | 2020-07-20 | 2020-07-22 | $11.42 | $69K | -0.7% | -18.3% | -28.0% |
| GWPH | SELL | 2020-03-02 | 2020-03-04 | $8.32 | $28K | -28.2% | -18.9% | +26.2% |
| GWPH | SELL | 2020-02-26 | 2020-02-28 | $9.18 | $28K | -15.1% | -16.8% | +22.5% |
| GWPH | SELL | 2019-05-20 | 2019-05-21 | $14.64 | $356K | -4.7% | -4.6% | -16.4% |
| GWPH | SELL | 2019-05-15 | 2020-06-19 | $11.73 | $312K | -2.4% | +7.5% | -21.1% |
| GWPH | SELL | 2019-03-01 | 2019-03-05 | $14.46 | $54K | -1.7% | -6.1% | +2.0% |
| GWPH | SELL | 2019-03-01 | 2019-03-05 | $14.46 | $54K | -1.7% | -6.1% | +2.0% |
| GWPH | SELL | 2019-02-26 | 2019-02-28 | $12.46 | $52K | -1.4% | -3.1% | +4.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.